210 related articles for article (PubMed ID: 5133607)
1. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
Housholder GE; Loo TL
J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
[No Abstract] [Full Text] [Related]
2. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
Mizuno NS; Humphrey EW
Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
[No Abstract] [Full Text] [Related]
3. [Metabolism of oxaflumazine].
Boissier JR; Gérardin A; Dumont C
Ann Pharm Fr; 1972 Dec; 30(12):851-60. PubMed ID: 4148298
[No Abstract] [Full Text] [Related]
4. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
Vogel CL; Denham C; Waalkes TP; DeVita VT
Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
[No Abstract] [Full Text] [Related]
5. Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.
Gerulath AH; Loo TL
Biochem Pharmacol; 1972 Sep; 21(17):2335-43. PubMed ID: 4675028
[No Abstract] [Full Text] [Related]
6. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.
Skibba JL; Ramirez G; Beal DD; Bryan GT
Biochem Pharmacol; 1970 Jun; 19(6):2043-51. PubMed ID: 5513972
[No Abstract] [Full Text] [Related]
7. Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
Saunders PP; Chao LY
Cancer Res; 1974 Oct; 34(10):2464-9. PubMed ID: 4472112
[No Abstract] [Full Text] [Related]
8. Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide.
Loo TL; Luce JK; Jardine JH; Frei E
Cancer Res; 1968 Dec; 28(12):2448-53. PubMed ID: 5728154
[No Abstract] [Full Text] [Related]
9. [Studies on the fate of the antidepressant amitriptyline in the organism of the rat and man].
Eschenhof E; Rieder J
Arzneimittelforschung; 1969 Jun; 19(6):957-66. PubMed ID: 5820041
[No Abstract] [Full Text] [Related]
10. [Preliminary report on the intestinal absorption of acetyldigoxin (Lanatiline) in comparison with digoxin using radioactive labelling substances].
Buchtela K; Hackl H; Königstein M; Schläger J
Wien Med Wochenschr; 1968 Feb; 118(5):86-93. PubMed ID: 5664025
[No Abstract] [Full Text] [Related]
11. N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
Skibba JL; Beal DD; Ramirez G; Bryan GT
Cancer Res; 1970 Jan; 30(1):147-50. PubMed ID: 5441073
[No Abstract] [Full Text] [Related]
12. Species differences in the physiological disposition of 3-tritylthio-L-alanine (NSC83265).
Coffey JJ; Palm PE; Denine EP; Baronowsky PE; Kensler CJ
Cancer Res; 1971 Dec; 31(12):1908-14. PubMed ID: 5000977
[No Abstract] [Full Text] [Related]
13. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Carter SK; Friedman MA
Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
[No Abstract] [Full Text] [Related]
14. The absorption of 1,6-dibromo-1,6-didesoxy-d-mannitol in normal and in tumour-bearing rats.
Csányi E
Arzneimittelforschung; 1967 Jan; 17(1):52-5. PubMed ID: 5632528
[No Abstract] [Full Text] [Related]
15. [Distribution and excretion of aurantin-Cl4 from intact mice and mice with transplantable tumors].
Suskova VS; Khasigov PZ; Chernov VA; Karpov VL; Serebriakov NG
Antibiotiki; 1970 May; 15(5):437-41. PubMed ID: 4193821
[No Abstract] [Full Text] [Related]
16. [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].
Rehbinder D; Deckers W
Arzneimittelforschung; 1969 Feb; 19(2):169-76. PubMed ID: 5818753
[No Abstract] [Full Text] [Related]
17. Role of 4-diazoimidazole-5-carboxamide in the action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4-(5)carboxamide in Bacillus subtilis.
Saunders PP; Schultz GA
Biochem Pharmacol; 1972 Aug; 21(15):2065-76. PubMed ID: 4630320
[No Abstract] [Full Text] [Related]
18. Microsomal metabolism of triazenylimidazoles.
Hill DL
Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
[TBL] [Abstract][Full Text] [Related]
19. Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide.
Housholder GE; Loo TL
Life Sci; 1969 May; 8(9):533-6. PubMed ID: 5791705
[No Abstract] [Full Text] [Related]
20. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
Skibba JL; Ramirez G; Beal DD; Bryan GT
Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
